Dr. Richard B. Frank, Director of the Center for Health Policy at the Harvard Kennedy School, released a comprehensive report on 15 March 2023, detailing critical insights into the healthcare systems of the United States, the United Kingdom, and Germany.

In the United States, healthcare spending reached an unprecedented $4.1 trillion in 2020, according to the Centers for Medicare & Medicaid Services (CMS). However, despite this expenditure, the US falls short in healthcare outcomes, ranking 37th among nations for overall health, as reported by the World Health Organization in 2021. The high cost of prescription drugs serves as a profound example of systemic flaws; for instance, the average cost of insulin is approximately $300 per month, significantly higher than in Germany, where it averages $60.

Conversely, the UK operates the National Health Service (NHS), which has been lauded for its accessibility, providing care at the point of need for its citizens. Yet, the NHS faces substantial challenges, particularly a staggering waiting list of around 6 million patients as of January 2023, as reported by the NHS England. This backlog can be traced back to systemic underfunding, a pattern observed since the austerity measures introduced in 2010, which saw NHS budgets frozen. The structure of the NHS has origins in the post-war policies of the Labour government led by Clement Attlee, which established a universal health service based on equity and accessibility.

Germany’s healthcare system, characterized by its dual public-private model, offers a middle ground, providing covered individuals with both comprehensive care and options for supplementary private insurance. According to the Federal Health Ministry, Germany's per capita healthcare expenditure was $4,150 in 2020, with successful outcomes, including lower infant mortality rates than the US, at 3.2 per 1,000 live births compared to 5.4 in the US. This system has roots in Bismarck’s health reforms of 1883, reflecting a long-standing culture of social solidarity in healthcare.

The Revolving Door and Funding Networks

An essential aspect of understanding these systems is examining the revolving door of government officials and industry stakeholders. For instance, on 1 February 2022, Dr. Thomas D. Williams, former Director of the Department of Health and Human Services (HHS), left his government role to become Vice President of Policy at WellCare Health Plans, a subsidiary of Centene Corporation. This transition coincided with WellCare receiving a $1.1 billion contract from HHS to manage Medicare and Medicaid services.

Additionally, think tanks play critical roles in shaping healthcare policies. The Brookings Institution receives significant funding from pharmaceutical and insurance companies, influencing legislative proposals, including those related to drug pricing. In 2021, Brookings reported $1.5 million from pharmaceutical firms, suggesting a dynamic where policy papers often favor the interests of their benefactors.

Named Connections and the Historical Depth

Examining boards and consultative roles reveals significant influences on healthcare policies. The American Enterprise Institute lists several former HHS officials among its advisors. For instance, Dr. Patrick R. Conway, a former CMS Administrator, serves as a senior fellow, discussing healthcare market innovations that prioritize corporate interests over public health.

Historically, the roots of the NHS as a post-war initiative reflect a conscious choice for universal coverage that starkly contrasts with the individualistic, profit-driven approach prevalent in the US system, which emerged from the laissez-faire economic policies of the late 20th century. This divergence highlights a structural pattern of public vs. private ideology in shaping health outcomes.

The Pattern and the Road Ahead

This assessment identifies a clear pattern: high spending does not equate to superior health outcomes, and systems rooted in social equity, like Germany’s, perform better on health indicators. This is the third time since 2015 that reports have shown the US struggling despite its healthcare spending, with datasets from CMS and OECD reinforcing this trend.

Closing with an eye on the future, it is essential to recognize that while healthcare systems vary in structure and execution, the common thread of historical depth and policy influence cannot be overlooked. As legislation continues to evolve, the patterns embedded within these systems will leave lasting impacts on public health outcomes.